CClinicalTrials.gg
CompletedNCT05627141Updated Apr 14, 2026

Photobiomodulation, Cryotherapy Combined With Compression, and Massage for Recovery

An interventional study of Photobiomodulation; Cryotherapy, Massage in Laser, Muscle; Fatigue, Heart and Muscle Damage, sponsored by Universidade Anhanguera. Completed at 1 site in Brazil. Open to male participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-14.

Sponsored by Universidade Anhanguera · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Male
01

Study summary

Skeletal muscle fatigue is an inevitable phenomenon in the training and competition routine for many crossfit athletes, which can impair their physical performance and predispose them to musculoskeletal injuries. Thus, strategies and/or therapies that minimize fatigue and accelerate muscle recovery are extremely relevant for everyone involved with sport. The aim of the present study is to investigate and compare the effects of photobiomodulation, cryotherapy combined with compression, and massage as isolated therapies for muscle recovery after a protocol of induced muscle damage and fatigue in Crossfit athletes. This is a randomized, double-blind, crossover, sham-controlled clinical trial. Will be recruited 60 male participants, adults, aged between 18 and 40 years, Crossfit practitioners. They will be randomly allocated into 3 groups of 20 participants per therapy, each crossed between effective and sham every 15 days. The primary outcome will be muscle performance in functional test (free squat) and knee extensor torque in maximal voluntary isometric contraction (MVIC). Secondary outcomes will be evaluated by the levels of muscle damage via creatine phosphokinase (CPK) and inflammatory process via blood C-reactive protein (CRP); and delayed onset muscle pain via numerical verbal scale (0-10). All outcomes will be evaluated at baseline, 24h and 48h after induction of muscle damage and fatigue. Data will be analyzed and compared intra and inter groups with a significance level of 5%.

Read the detailed description

This is a randomized, double-blind, crossover, controlled clinical trial of sham therapy.

02

Conditions studied

  • Laser
  • Muscle; Fatigue, Heart
  • Muscle Damage

Browse trials for

Keywords

  • Photobiomodulation
  • Crossfit
  • Muscle Damage
03

In context

Fatigue

1,860 studies on the registry are indexed under Fatigue; 376 are open to participants now.

This study's enrollment of 60 is above the median of 54 across 1,440 interventional studies indexed under Fatigue.

Browse Fatigue studies →

Lead sponsor

This is the only study on the registry with Universidade Anhanguera as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Male participants;
  • Adults; aged between 18 and 40 years;
  • Body mass index (BMI) between 18 and 30 kg/m2;
  • Crossfit practitioners of the scale, amateur, RX and elite categories;
  • Training at least 5 days a week.

Exclusion criteria

Exclusion Criteria:

  • Orthopedic injuries in the lower limbs (2 months) or during the development of the study will be excluded;
  • Participants with less than 5 training sessions per week;
  • Participants making regular use of pharmacological agents and/or ergogenic supplements;
  • Participants who regularly use alcohol and/or tobacco;
  • Participants with skin lesions (open wounds) on the lower limbs.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Photobiomodulation

    10 participants will receive active photobiomodulation immediately after the muscle damage and fatigue induction protocol in a randomized and crossover manner, with an interval of 15 days between each evaluation session

    Other: Photobiomodulation; Cryotherapy, Massage

  • Sham comparator
    Sham Photobiomodulation

    10 participants will receive sham photobiomodulation immediately after the muscle damage and fatigue induction protocol in a randomized and crossover manner, with an interval of 15 days between each evaluation session

    Other: Photobiomodulation; Cryotherapy, Massage

  • Experimental
    Active Cryotherapy

    10 participants will receive effective cryotherapy (10-12°C for 20 min) combined with high compression on the lower limbs, or sham (25°C for 20 min) damage and fatigue induction protocol. muscle.

    Other: Photobiomodulation; Cryotherapy, Massage

  • Sham comparator
    Sham Cryotherapy

    10 participants will receive sham cryotherapy (25°C for 20 min) combined with light compression on the lower limbs immediately after the damage and fatigue induction protocol. muscle.

    Other: Photobiomodulation; Cryotherapy, Massage

  • Experimental
    Massage

    10 participants will receive the effective massage immediately after the muscle damage and fatigue induction protocol in a randomized and crossover manner, with an interval of 15 days between each evaluation session.

    Other: Photobiomodulation; Cryotherapy, Massage

  • Sham comparator
    Sham Massage

    10 participants will receive the sham massage immediately after the muscle damage and fatigue induction protocol in a randomized and crossover manner, with an interval of 15 days between each evaluation session.

    Other: Photobiomodulation; Cryotherapy, Massage

Interventions

  • OtherPhotobiomodulation; Cryotherapy, Massage

    Photobiomodulation: the 20 participants will receive active photobiomodulation or sham immediately after the muscle damage and fatigue induction protocol in a randomized and crossover manner, with an interval of 15 days between each evaluation session. Cryotherapy combined with compression: the 20 participants will receive effective cryotherapy (10-12°C for 20 min) combined with high compression, or sham (25°C for 20 min) combined with light compression, on the lower limbs, immediately after the protocol. induction of muscle damage and fatigue. Effective cryotherapy or sham will be applied in a randomized and crossover manner, with an interval of 15 days between each evaluation session. Massage: the 20 participants will receive the effective massage or sham immediately after the muscle damage and fatigue induction protocol in a randomized and crossover manner, with an interval of 15 days between each evaluation session.

06

What researchers measure

Primary outcomes

  1. Muscle Force Dynamometry

    participants will be evaluated regarding the dominant knee extensor torque during maximal voluntary isometric contraction (MVIC) in an extensor chair.

    Time frame: 48 hours

  2. Blood markers of muscle damage and inflammatory process

    To measure the serum levels of CPK and CRP, blood samples will be collected after aseptic cleaning of the ventral side of the dominant arm. All blood collection procedures will be performed by a qualified nurse (who will not know to which group each participant will belong). Collections will be performed using vacuum collection tubes, without anticoagulant (10ml), centrifuged at 4,000g for 5 minutes, and stored at -80°C until analysis. Blood collections will be performed at baseline (before WOD and leg extension exercise), 24h and 48h after. Blood analysis will be performed using infrared spectrophotometry in a clinical analysis laboratory (Matter Diagnósticos, Campo Grande, MS) and by an evaluator who is blinded to the therapies applied.

    Time frame: 48 hours

  3. Delayed onset muscle pain

    The subjective perception of pain will be through a numerical verbal scale (NVS) graduated in centimeters (from 0 to 10), where 0 corresponds to no pain, and 10 corresponds to the maximum possible pain (HAWKER et al., 2011). Pain will be provoked in participants through CIVM for knee extension of the dominant lower limb, in full extension (0°) and without load (FERRARESI et al., 2016). Volunteers will be asked about the level of pain they will feel immediately before WOD and MVIC in a leg extension, 24h and 48h after.

    Time frame: 48 hours

07

Study locations

1 site
  • Filipe Abdalla
    Campo Grande, Mato Grosso do Sul 79117504, Brazil
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05627141
Lead sponsor
Universidade Anhanguera
Collaborators
Universidade Federal de Sao Carlos
Responsible party
Filipe Abdalla dos Reis, PhD (Universidade Anhanguera, Universidade Anhanguera) — Principal investigator
First posted
Nov 25, 2022
Start date
Mar 1, 2022
Primary completion
Jun 1, 2023
Completion
Jul 1, 2023
Last update
Apr 14, 2026

Study contacts

Filipe A dos Reis, PhD
principal investigator · Ufscar

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion